Open the News about your Business

  • Home
  • Finance
  • Asian Stock: Jiangsu Hengrui Pharmaceuticals

Asian Stock: Jiangsu Hengrui Pharmaceuticals

Nov 05, 2024Finance0

TM Editors’ note: This article discusses a penny stock and/or microcap. Such stocks are easily manipulated; do your own careful due diligence.Company: Jiangsu Hengrui Pharmaceuticals Company LimitedBloomberg ticker: 600276 SHMarket cap: US$40,126mBackground: Jiangsu Hengrui Pharmaceuticals Company Limited develops, manufactures, and markets medicines and medicine packing materials. The Company produces anti-tumor medicines, pain-killers, anti-infection medicines, aluminum foil, and other related products.
 World Class Benchmarking of Jiangsu Hengrui Pharmaceuticals

  • Profitable Growth rank of 2 was up compared to the prior period’s 3rd rank
  • This is World Class performance compared to 360 large Health Care companies worldwide
  • Profitability rank of 2 was better than its Growth rank of 3
  • Profitability rank of 2 was the same compared to the prior period’s 2nd rank
  • This is World Class performance compared to peers
  • Growth rank of 3 was up compared to the prior period’s 5th rank
  • This is above average performance compared to peers

    • More By This Author:Asian Stock: Zhejiang China Commodities City Group
    Asian Stock: President Chain Store Corp
    Asian Stock: Carabao Group

    Reviews

    • Total Score 0%
    User rating: 0.00% ( 0
    votes )
    SEC’s Crypto Mom emerges as favorite to replace Gensler under Trump

    Related articles

    Leave a Reply

    Your email address will not be published. Required fields are marked *